[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Tuberous Sclerosis pipeline...

April 2021 40 pages

Tubulin - Drugs in Development, 2021

 US$ 3,500.00

Tubulin - Drugs in Development, 2021 SUMMARY Tubulin - Drugs in Development, 2021 provides in depth analysis on Tubulin targeted pipeline therapeutics. The report provides comprehensive information co...

April 2021 325 pages

Tumor Necrosis Factor (Cachectin or TNF Alpha or Tumor Necrosis Factor Ligand Superfamily Member 2 or TNF a or TNF) - Drugs in Development, 2021

 US$ 3,500.00

Tumor Necrosis Factor (Cachectin or TNF Alpha or Tumor Necrosis Factor Ligand Superfamily Member 2 or TNF a or TNF) - Drugs in Development, 2021 SUMMARY Tumor Necrosis Factor (Cachectin or TNF Alpha o...

April 2021 230 pages

Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Turner Syndrome pipeline landscape...

April 2021 30 pages

Type 1 Angiotensin II Receptor (AT1AR or AT1BR or Angiotensin II Type 1 Receptor or AGTR1) - Drugs in Development, 2021

 US$ 3,000.00

Type 1 Angiotensin II Receptor (AT1AR or AT1BR or Angiotensin II Type 1 Receptor or AGTR1) - Drugs in Development, 2021 SUMMARY Type 1 Angiotensin II Receptor (AT1AR or AT1BR or Angiotensin II Type 1...

April 2021 85 pages

Tyrosine Protein Kinase Lyn (Lck/Yes Related Novel Protein Tyrosine Kinase or V Yes 1 Yamaguchi Sarcoma Viral Related Oncogene Homolog or p53Lyn or p56Lyn or LYN or EC 2.7.10.2) - Drugs in Development, 2021

 US$ 3,000.00

Tyrosine Protein Kinase Lyn (Lck/Yes Related Novel Protein Tyrosine Kinase or V Yes 1 Yamaguchi Sarcoma Viral Related Oncogene Homolog or p53Lyn or p56Lyn or LYN or EC 2.7.10.2) - Drugs in Development...

April 2021 40 pages

Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Drugs in Development, 2021

 US$ 3,000.00

Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Drugs in Deve...

April 2021 75 pages

Tyrosyl DNA Phosphodiesterase 1 (TDP1 or EC 3.1.4.) - Drugs in Development, 2021

 US$ 3,000.00

Tyrosyl DNA Phosphodiesterase 1 (TDP1 or EC 3.1.4.) - Drugs in Development, 2021 SUMMARY Tyrosyl DNA Phosphodiesterase 1 (TDP1 or EC 3.1.4.) - Drugs in Development, 2021 provides in depth analysis on...

April 2021 30 pages

Ulcers (Gastrointestinal) - Drugs in Development, 2021

 US$ 2,000.00

Ulcers (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Ulcers (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Ulcers pipeline landscape. The report provides compreh...

April 2021 30 pages

Undisclosed (Undisclosed) - Drugs in Development, 2021

 US$ 2,000.00

Undisclosed (Undisclosed) - Drugs in Development, 2021 SUMMARY Undisclosed (Undisclosed) - Drugs in Development, 2021 provides an overview of the Undisclosed pipeline landscape. The report provides co...

April 2021 40 pages

Upper Limb Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Upper Limb Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021 SUMMARY Upper Limb Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021 provides an overview of th...

April 2021 35 pages

Urea Cycle Disorders (Genetic Disorders) - Drugs in Development, 2021

 US$ 2,000.00

Urea Cycle Disorders (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Urea Cycle Disorders (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Urea Cycle Disorders pip...

April 2021 35 pages

Uremic (Renal) Pruritus (Dermatology) - Drugs in Development, 2021

 US$ 2,000.00

Uremic (Renal) Pruritus (Dermatology) - Drugs in Development, 2021 SUMMARY Uremic (Renal) Pruritus (Dermatology) - Drugs in Development, 2021 provides an overview of the Uremic (Renal) Pruritus pipeli...

April 2021 35 pages

Urethral Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Urethral Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Urethral Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Urethral Cancer pipeline landscape. The report provi...

April 2021 60 pages

Urinary Tract Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Urinary Tract Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Urinary Tract Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Urinary Tract Cancer pipeline landscape. T...

April 2021 35 pages

Urinary Tract Infections Due To Catheter Encrustation (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Urinary Tract Infections Due To Catheter Encrustation (Infectious Disease) - Drugs in Development, 2021 SUMMARY Urinary Tract Infections Due To Catheter Encrustation (Infectious Disease) - Drugs in De...

April 2021 30 pages

Urinary Tract Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Urinary Tract Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Urinary Tract Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Urinary Tract...

April 2021 160 pages

Urticaria Pigmentosa (Mastocytosis, Mastocytoma) (Dermatology) - Drugs in Development, 2021

 US$ 2,000.00

Urticaria Pigmentosa (Mastocytosis, Mastocytoma) (Dermatology) - Drugs in Development, 2021 SUMMARY Urticaria Pigmentosa (Mastocytosis, Mastocytoma) (Dermatology) - Drugs in Development, 2021 provides...

April 2021 30 pages

Usherin (Usher Syndrome Type 2A Protein or USH2A) - Drugs in Development, 2021

 US$ 3,000.00

Usherin (Usher Syndrome Type 2A Protein or USH2A) - Drugs in Development, 2021 SUMMARY Usherin (Usher Syndrome Type 2A Protein or USH2A) - Drugs in Development, 2021 provides in depth analysis on Ushe...

April 2021 35 pages

Uterine Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Uterine Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Uterine Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Uterine Cancer pipeline landscape. The report provides...

April 2021 110 pages

Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) - Drugs in Development, 2021

 US$ 3,000.00

Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) - Drugs in Development, 2021 SUMMARY Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) - Drugs in Development, 2021 provides in depth anal...

April 2021 30 pages

Varicella Zoster (HHV-3) Infections (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Varicella Zoster (HHV-3) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Varicella Zoster (HHV-3) Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview...

April 2021 35 pages

Vascular Dementias (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Vascular Dementias (Central Nervous System) - Drugs in Development, 2021 SUMMARY Vascular Dementias (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Vascular Dementias...

April 2021 45 pages

Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) - Drugs in Development, 2021

 US$ 3,500.00

Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) - Drugs in Development, 2021 SUMMARY Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) - Drugs i...

April 2021 210 pages

Vascular Endothelial Growth Factor C (Flt4 Ligand or Vascular Endothelial Growth Factor Related Protein or VEGFC) - Drugs in Development, 2021

 US$ 3,000.00

Vascular Endothelial Growth Factor C (Flt4 Ligand or Vascular Endothelial Growth Factor Related Protein or VEGFC) - Drugs in Development, 2021 SUMMARY Vascular Endothelial Growth Factor C (Flt4 Ligand...

April 2021 30 pages

Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or FIGF) - Drugs in Development, 2021

 US$ 3,000.00

Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or FIGF) - Drugs in Development, 2021 SUMMARY Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or F...

April 2021 30 pages

Vascular Endothelial Growth Factor Receptor (VEGFR or EC 2.7.10.1) - Drugs in Development, 2021

 US$ 3,000.00

Vascular Endothelial Growth Factor Receptor (VEGFR or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Vascular Endothelial Growth Factor Receptor (VEGFR or EC 2.7.10.1) - Drugs in Development, 2021...

April 2021 75 pages

Vascular Endothelial Growth Factor (VEGF) - Drugs in Development, 2021

 US$ 3,500.00

Vascular Endothelial Growth Factor (VEGF) - Drugs in Development, 2021 SUMMARY Vascular Endothelial Growth Factor (VEGF) - Drugs in Development, 2021 provides in depth analysis on Vascular Endothelial...

April 2021 190 pages

Vascular Injury (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Vascular Injury (Cardiovascular) - Drugs in Development, 2021 SUMMARY Vascular Injury (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Vascular Injury pipeline landscape. The...

April 2021 30 pages

Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) - Drugs in Development, 2021

 US$ 2,000.00

Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) - Drugs in Development, 2021 SUMMARY Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) - Drugs in Development, 2021 provides...

April 2021 45 pages

Vasopressin V1a Receptor (AVPR V1a or Antidiuretic Hormone Receptor 1a or Vascular/Hepatic Type Arginine Vasopressin Receptor or AVPR1A) - Drugs in Development, 2021

 US$ 3,000.00

Vasopressin V1a Receptor (AVPR V1a or Antidiuretic Hormone Receptor 1a or Vascular/Hepatic Type Arginine Vasopressin Receptor or AVPR1A) - Drugs in Development, 2021 SUMMARY Vasopressin V1a Receptor (...

April 2021 40 pages

Venezuelan Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021

 US$ 2,000.00

Venezuelan Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Venezuelan Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Ve...

April 2021 40 pages

Venous Thromboembolism (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Venous Thromboembolism (Cardiovascular) - Drugs in Development, 2021 SUMMARY Venous Thromboembolism (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Venous Thromboembolism pip...

April 2021 50 pages

Venous (Vein) Thrombosis (Cardiovascular) - Drugs in Development, 2021

 US$ 2,000.00

Venous (Vein) Thrombosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Venous (Vein) Thrombosis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Venous (Vein) Thrombos...

April 2021 35 pages

Vestibular Schwannoma (Acoustic Neuroma) (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Vestibular Schwannoma (Acoustic Neuroma) (Oncology) - Drugs in Development, 2021 SUMMARY Vestibular Schwannoma (Acoustic Neuroma) (Oncology) - Drugs in Development, 2021 provides an overview of the Ve...

April 2021 35 pages

Vimentin (Epididymis Luminal Protein 113 or VIM) - Drugs in Development, 2021

 US$ 3,000.00

Vimentin (Epididymis Luminal Protein 113 or VIM) - Drugs in Development, 2021 SUMMARY Vimentin (Epididymis Luminal Protein 113 or VIM) - Drugs in Development, 2021 provides in depth analysis on Viment...

April 2021 30 pages

Viral Respiratory Tract Infection (Respiratory) - Drugs in Development, 2021

 US$ 2,000.00

Viral Respiratory Tract Infection (Respiratory) - Drugs in Development, 2021 SUMMARY Viral Respiratory Tract Infection (Respiratory) - Drugs in Development, 2021 provides an overview of the Viral Resp...

April 2021 35 pages

Virion Infectivity Factor (SOR Protein or vif) - Drugs in Development, 2021

 US$ 3,000.00

Virion Infectivity Factor (SOR Protein or vif) - Drugs in Development, 2021 SUMMARY Virion Infectivity Factor (SOR Protein or vif) - Drugs in Development, 2021 provides in depth analysis on Virion Inf...

April 2021 35 pages

Visceral Pain (Central Nervous System) - Drugs in Development, 2021

 US$ 2,000.00

Visceral Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Visceral Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Visceral Pain pipeline lands...

April 2021 50 pages

Vitamin D3 Receptor (1,25 Dihydroxyvitamin D3 Receptor or Nuclear Receptor Subfamily 1 Group I Member 1 or NR1I1 or VDR) - Drugs in Development, 2021

 US$ 3,000.00

Vitamin D3 Receptor (1,25 Dihydroxyvitamin D3 Receptor or Nuclear Receptor Subfamily 1 Group I Member 1 or NR1I1 or VDR) - Drugs in Development, 2021 SUMMARY Vitamin D3 Receptor (1,25 Dihydroxyvitamin...

April 2021 45 pages

Voltage Dependent Calcium Channel - Drugs in Development, 2021

 US$ 3,000.00

Voltage Dependent Calcium Channel - Drugs in Development, 2021 SUMMARY Voltage Dependent Calcium Channel - Drugs in Development, 2021 provides in depth analysis on Voltage Dependent Calcium Channel ta...

April 2021 35 pages

Voltage Dependent Calcium Channel Subunit Alpha2/Delta1 (CACNA2D1) - Drugs in Development, 2021

 US$ 3,000.00

Voltage Dependent Calcium Channel Subunit Alpha2/Delta1 (CACNA2D1) - Drugs in Development, 2021 SUMMARY Voltage Dependent Calcium Channel Subunit Alpha2/Delta1 (CACNA2D1) - Drugs in Development, 2021...

April 2021 50 pages

Voltage Dependent Calcium Channel Subunit Alpha2/Delta2 (CACNA2D2) - Drugs in Development, 2021

 US$ 3,000.00

Voltage Dependent Calcium Channel Subunit Alpha2/Delta2 (CACNA2D2) - Drugs in Development, 2021 SUMMARY Voltage Dependent Calcium Channel Subunit Alpha2/Delta2 (CACNA2D2) - Drugs in Development, 2021...

April 2021 35 pages

Voltage Dependent L Type Calcium Channel - Drugs in Development, 2021

 US$ 3,000.00

Voltage Dependent L Type Calcium Channel - Drugs in Development, 2021 SUMMARY Voltage Dependent L Type Calcium Channel - Drugs in Development, 2021 provides in depth analysis on Voltage Dependent L Ty...

April 2021 50 pages

Voltage Dependent T Type Calcium Channel - Drugs in Development, 2021

 US$ 3,000.00

Voltage Dependent T Type Calcium Channel - Drugs in Development, 2021 SUMMARY Voltage Dependent T Type Calcium Channel - Drugs in Development, 2021 provides in depth analysis on Voltage Dependent T Ty...

April 2021 35 pages

Voltage Dependent T Type Calcium Channel Subunit Alpha 1G (Voltage Gated Calcium Channel Subunit Alpha Cav3.1 or CACNA1G) - Drugs in Development, 2021

 US$ 3,000.00

Voltage Dependent T Type Calcium Channel Subunit Alpha 1G (Voltage Gated Calcium Channel Subunit Alpha Cav3.1 or CACNA1G) - Drugs in Development, 2021 SUMMARY Voltage Dependent T Type Calcium Channel...

April 2021 30 pages

Voltage Dependent T Type Calcium Channel Subunit Alpha 1H (Voltage Gated Calcium Channel Subunit Alpha Cav3.2 or CACNA1H) - Drugs in Development, 2021

 US$ 3,000.00

Voltage Dependent T Type Calcium Channel Subunit Alpha 1H (Voltage Gated Calcium Channel Subunit Alpha Cav3.2 or CACNA1H) - Drugs in Development, 2021 SUMMARY Voltage Dependent T Type Calcium Channel...

April 2021 35 pages

Voltage Gated Sodium Channel (SCN) - Drugs in Development, 2021

 US$ 3,000.00

Voltage Gated Sodium Channel (SCN) - Drugs in Development, 2021 SUMMARY Voltage Gated Sodium Channel (SCN) - Drugs in Development, 2021 provides in depth analysis on Voltage Gated Sodium Channel (SCN)...

April 2021 110 pages

Von Willebrand Factor (VWF) - Drugs in Development, 2021

 US$ 3,000.00

Von Willebrand Factor (VWF) - Drugs in Development, 2021 SUMMARY Von Willebrand Factor (VWF) - Drugs in Development, 2021 provides in depth analysis on Von Willebrand Factor (VWF) targeted pipeline th...

April 2021 35 pages

Vulvar Cancer (Oncology) - Drugs in Development, 2021

 US$ 2,000.00

Vulvar Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Vulvar Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Vulvar Cancer pipeline landscape. The report provides co...

April 2021 80 pages

Filters

Clear all

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1